Parameter
| Biomarker | Activin-A | Full name | Activin A (Homodimer of Inhibin Beta A Subunits) | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis, prediction of treatment response | ||
| Disease | Acute Myeloid Leukemia (AML) | Disease Subtypes | / | ||
| Organ | Blood, bone marrow | Test Sample / Technology Platform | Bone marrow plasma (ELISA) | ||
| Pathobiological Mechanisms | Highly expressed during diagnosis, downregulated after complete remission, and elevated again upon recurrence. | ||||
| Clinical Availability Status | Research validation: 80 AML patient samples confirm its value. | ||||
| Notes and Dynamics | Predictable induction response and relapse risk, evaluation of patient outcomes. | ||||